• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?犬类心脏心室中Kv1.5是否存在功能相关性,以及这对I(Kur)阻滞剂的使用意味着什么?
Br J Pharmacol. 2007 Nov;152(6):835-7. doi: 10.1038/sj.bjp.0707463. Epub 2007 Sep 17.
2
In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate.新型二苯基氧化膦IKur阻滞剂(2-异丙基-5-甲基环己基)二苯基氧化膦在大鼠和非人灵长类动物体内的心脏电生理效应
J Pharmacol Exp Ther. 2006 Feb;316(2):727-32. doi: 10.1124/jpet.105.094839. Epub 2005 Oct 21.
3
Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.新型I(Kur)通道阻滞剂S9947和S20951与I(Kr)阻滞剂多非利特、阿齐利特、d,l-索他洛尔和伊布利特相比,对猪左、右心房的电生理和抗心律失常作用。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):482-7. doi: 10.1007/s00210-002-0599-x. Epub 2002 Sep 5.
4
The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.犬心室中的平台外向电流对4-氨基吡啶敏感,是心室复极化的一个组成性因素。
Br J Pharmacol. 2007 Nov;152(6):870-9. doi: 10.1038/sj.bjp.0707403. Epub 2007 Aug 13.
5
Presence and functional role of the rapidly activating delayed rectifier K(+) current in left and right atria of adult mice.成年小鼠左右心房中快速激活延迟整流钾(K+)电流的存在和功能作用。
Eur J Pharmacol. 2010 Dec 15;649(1-3):14-22. doi: 10.1016/j.ejphar.2010.08.025. Epub 2010 Sep 6.
6
Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.超快速延迟整流钾通道:分子基础与治疗意义。
Cardiovasc Res. 2011 Mar 1;89(4):776-85. doi: 10.1093/cvr/cvq398. Epub 2010 Dec 15.
7
Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.Kv1.5是犬心房肌细胞复极化钾电流的重要组成部分。
Circ Res. 2003 Oct 17;93(8):744-51. doi: 10.1161/01.RES.0000096362.60730.AE. Epub 2003 Sep 18.
8
Long-term 4-AP treatment facilitates functional expression of human Kv1.5 channel.长期使用 4-AP 处理可促进人 Kv1.5 通道的功能表达。
Eur J Pharmacol. 2019 Feb 5;844:195-203. doi: 10.1016/j.ejphar.2018.12.022. Epub 2018 Dec 12.
9
Four and a half LIM protein 1: a partner for KCNA5 in human atrium.四和半LIM结构域蛋白1:人类心房中KCNA5的一个结合蛋白
Cardiovasc Res. 2008 Jun 1;78(3):449-57. doi: 10.1093/cvr/cvn038. Epub 2008 Feb 15.
10
I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.用于治疗心房颤动的I(Kur)/Kv1.5通道阻滞剂
Expert Opin Investig Drugs. 2009 Apr;18(4):399-416. doi: 10.1517/13543780902762850.

引用本文的文献

1
The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.窦房结中 mRNA 表达模式在 Goto-Kakizaki 型 2 型糖尿病大鼠心脏中发生改变。
J Diabetes Res. 2018 Sep 2;2018:8454078. doi: 10.1155/2018/8454078. eCollection 2018.
2
Polyunsaturated Fatty acids modify the gating of kv channels.多不饱和脂肪酸会改变钾离子通道的门控特性。
Front Pharmacol. 2012 Sep 10;3:163. doi: 10.3389/fphar.2012.00163. eCollection 2012.
3
Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure.新型心房选择性钾通道阻滞剂AVE0118在实验性心力衰竭中的安全性
Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):225-32. doi: 10.1007/s00210-008-0361-0. Epub 2008 Oct 30.

本文引用的文献

1
The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.犬心室中的平台外向电流对4-氨基吡啶敏感,是心室复极化的一个组成性因素。
Br J Pharmacol. 2007 Nov;152(6):870-9. doi: 10.1038/sj.bjp.0707403. Epub 2007 Aug 13.
2
Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes.Rab-GTP酶依赖性心房肌细胞中Kv1.5的内吞再循环
J Biol Chem. 2007 Oct 5;282(40):29612-20. doi: 10.1074/jbc.M704402200. Epub 2007 Aug 2.
3
Novel anti-arrhythmic drugs for atrial fibrillation management.用于心房颤动管理的新型抗心律失常药物。
Curr Vasc Pharmacol. 2007 Jul;5(3):185-95. doi: 10.2174/157016107781024073.
4
Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.非病变人类心脏中离子通道基因的区域和组织特异性转录特征
J Physiol. 2007 Jul 15;582(Pt 2):675-93. doi: 10.1113/jphysiol.2006.126714. Epub 2007 May 3.
5
Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange.阻断心房特异性钾电流通过增强反向模式钠/钙交换来增加心房而非心室的收缩性。
Cardiovasc Res. 2007 Jan 1;73(1):37-47. doi: 10.1016/j.cardiores.2006.11.024. Epub 2006 Nov 23.
6
Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.心房特异性药物AVE0118在患有慢性完全性房室传导阻滞的麻醉犬中不会引发尖端扭转型室性心动过速。
Heart Rhythm. 2006 Nov;3(11):1339-45. doi: 10.1016/j.hrthm.2006.07.017. Epub 2006 Jul 20.
7
Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.新型、强效的人类Kv1.5钾通道抑制剂及超快速激活延迟整流钾电流。
J Pharmacol Exp Ther. 2006 Jun;317(3):1054-63. doi: 10.1124/jpet.106.101162. Epub 2006 Mar 7.
8
In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide.新型二苯基氧化膦IKur阻滞剂(2-异丙基-5-甲基环己基)二苯基氧化膦的体内抗心律失常及心脏电生理效应
J Pharmacol Exp Ther. 2005 Dec;315(3):1362-7. doi: 10.1124/jpet.105.092197. Epub 2005 Sep 12.
9
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.IKur在控制人类心房动作电位形态和收缩性中的作用:慢性心房颤动的影响
Circulation. 2004 Oct 19;110(16):2299-306. doi: 10.1161/01.CIR.0000145155.60288.71. Epub 2004 Oct 11.
10
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.用于治疗心房颤动的“早期”Ⅲ类药物:AVE0118在山羊重构心房中的疗效及心房选择性
Circulation. 2004 Sep 28;110(13):1717-24. doi: 10.1161/01.CIR.0000143050.22291.2E. Epub 2004 Sep 13.

犬类心脏心室中Kv1.5是否存在功能相关性,以及这对I(Kur)阻滞剂的使用意味着什么?

Is there a functional correlate of Kv1.5 in the ventricle of canine heart and what would it mean for the use of I(Kur) blockers?

作者信息

Wettwer E

机构信息

Department of Pharmacology and Toxicology, Medical Faculty, Dresden University of Technology, Dresden, Germany.

出版信息

Br J Pharmacol. 2007 Nov;152(6):835-7. doi: 10.1038/sj.bjp.0707463. Epub 2007 Sep 17.

DOI:10.1038/sj.bjp.0707463
PMID:17876301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2078221/
Abstract

The cardiac ultrarapid outward current I(Kur), encoded by KCNA5, is of special pharmacological interest, because it is considered to be atrium-specific. I(Kur) has therefore become a target in the therapy of atrial tachyarrhythmias. However, the concept of atrium specificity is only valid if a functional I(Kur) current is in fact absent from the ventricle. However, new work has detected a I(Kur)-like current in canine ventricular myocytes, sensitive to 4-aminopyridine and suppressed by the I(Kur) blocker DPO-1, findings that support the existence of a functional ventricular I(Kur). These indications are, however, indirect and more effort is needed to clarify unequivocally the putative role of an expectedly small I(Kur) component in the ventricle.

摘要

由KCNA5编码的心脏超快速外向电流I(Kur)具有特殊的药理学意义,因为它被认为是心房特异性的。因此,I(Kur)已成为治疗房性快速心律失常的一个靶点。然而,只有当心室中实际上不存在功能性I(Kur)电流时,心房特异性的概念才成立。然而,新的研究在犬心室肌细胞中检测到一种类似I(Kur)的电流,该电流对4-氨基吡啶敏感,并被I(Kur)阻滞剂DPO-1抑制,这些发现支持了功能性心室I(Kur)的存在。然而,这些迹象是间接的,需要更多的努力来明确阐明预期较小的I(Kur)成分在心室中的假定作用。